Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic, proteomic, and tissue array profiling

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5243-5250

  Nishizuka, Satoshi ^a   Chen, Sing Tsung ^a,e   Gwadry, Fuad G ^a,f   Alexander, Jes ^a,g   Major, Sylvia M ^a   Scherf, Uwe ^a,f   Reinhold, William C ^a   Waltham, Mark ^a,h   Charboneau, Lu ^a   Young, Lynn ^b   Bussey, Kimberly J ^a   Kim, Sohyoung ^a   Lababidi, Samir ^a   Lee, Jae K ^a,i   Pittaluga, Stefania ^a   Scudiero, Dominic A ^c   Sausville, Edward A ^a   Munson, Peter J ^b   Petricoin III, Emmanuel F ^d   Liotta, Lance A ^a   Hewitt, Stephen M ^a   Raffeld, Mark ^a   Weinstein, John N ^a,b   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d Division of Viral Products   (United States)

^e Uslabs   (United States)

^f Gene Logic Inc   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 20; CYTOKERATIN 7; MESSENGER RNA; MOESIN; OLIGONUCLEOTIDE; PROTEIN HYDROLYSATE; VILLIN;

ARTICLE; CANCER DIAGNOSIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENOMICS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS;

ADENOCARCINOMA; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENOMICS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDE PROBES; OVARIAN NEOPLASMS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0141816860     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gersell, D. J. Metastatic ovarian tumors: still a challenge. Am. J. Clin. Pathol., 97: 745-747, 1992.
2. Daya, D., Nazerali, L., and Frank, G. L. Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. Am. J. Clin. Pathol., 97: 751-758, 1992.
3. Wauters, C. C., Smedts, F., Gerrits, L. G., Bosman, F. T., and Ramaekers, F. C. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum. Pathol., 26: 852-855, 1995.
4. Loy, T. S., Calaluce, R. D., and Keeney, G. L. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod. Pathol., 9: 1040-1044, 1996.
5. Lagendijk, J. H., Mullink, H., Van Diest, P. J., Meijer, G. A., and Meijer, C. J. L. M. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry. Hum. Pathol., 29: 491-497, 1998.
6. Multhaupt, H. A. B., Arenas-Elliott, C. P., and Warhol, M. J. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch. Pathol. Lab. Med., 123: 909-916, 1999.
7. Ulbright, T. M., Lawrence, M. R., and Stehman, F. B. Secondary ovarian neoplasia. Cancer (Phila.), 53: 1164-1174, 1984.
8. Hainsworth, J. D., and Greco, F. A. Management of patients with cancer of unknown primary site. Oncology (Basel), 14: 563-574, 2000.
9. Greco, F. A., Burris, H. A., III, Erland, J. B., Gray, J. R., Kalman, L. A., Schreeder, M. T., and Hainsworth, J. D. Carcinoma of unknown primary site. Cancer (Phila.), 89: 2655-2660, 2000.
10. Brown, R. W., Campagna, L. B., Dunn, J. K., and Cagle, P. T. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. Am. J. Clin. Pathol., 107: 12-19, 1997.
11. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1142, 1994.
12. Qazi, F., and McGuire, W. P. The treatment of epithelial ovarian cancer. CA Cancer J. Clin., 45: 88-101, 1995.
13. Grever, M. R., Schepartz, S. A., and Chabner, B. A. The National Cancer Institute: cancer drug discovery and development program. Semin. Oncol., 19: 622-638, 1992.
14. Boyd, M. R., and Paull, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res., 34: 91-109, 1995.
15. Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fomace, A. J., Jr., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., Buolamwini, J. K., van Osdol, W. W., Monks, A. P., Scudiero, D. A., Sausville, E. A., Zaharevitz, D. W., Bunow, B., Viswanadhan, V. N., Johnson, G. S., Wittes, R. E., and Paull, K. D. An information-intensive approach to the molecular pharmacology of cancer. Science (Wash. DC), 275: 343-349, 1997.
16. Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., and Boyd, M. R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. (Bethesda), 81: 1088-1092, 1989.
17. Weinstein, J. N., Kohn, K. W., Grever, M. R., Viswanadhan, V. N., Rubinstein, L. V., Monks, A. P., Scudiero, D. A., Welch, L., Koutsoukos, A. D., Chiausa, A. J., and Paull, K. D. Neural computing in cancer drug development: predicting mechanism of action. Science (Wash. DC). 258: 447-451, 1992.
18. Myers, T. G., Waltham, M., Li, G., Buolamwini, J. K., Scudiero, D. A., Rubinstein, L. V., Paull, K. D., Sausville, E. A., Anderson, N. L., and Weinstein, J. N. A protein expression database for the molecular pharmacology of cancer. Electrophoresis, 18: 647-653, 1997.
19. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., Scudiero, D. A., Eisen, M. B., Sausville, E. A., Pommier, Y., Botstein, D., Brown, P. O., and Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24: 236-244, 2000.
20. Staunton, J. E., Slonim, D. K., Coller, H. A., Tamayo, P., Angelo, M, J., Park, J., Scherf, U., Lee, J. K., Weinstein, J. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA, 98: 10787-10792, 2001.
21. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., lyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C. F., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet., 24: 227-235, 2000.
22. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, E. F., III, and Liotta, L. A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene, 20: 1981-1989, 2001.
23. Liotta, L., and Petricoin, E. Molecular profiling of human cancer. Nat. Rev. Genet., 1: 48-56, 2000.
24. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
25. Stinson, S. F., Alley, M. C., Kopp, W. C., Fiebig, H. H., Mullendore, L. A., Pittman, A. F., Kenney, S., Keller, J., and Boyd, M. R. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res., 12: 1035-1053, 1992.
26. Zhou, Y., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y., and Weinstein, J. N. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dosc- and time-dependent effects. Cancer Res, 62: 1688-1695, 2002.
27. Carlisle, A. J., Prabhu, V. V., Elkahloun, A., Hudson, J., Trent, J. M., Linehan, W. M., Williams, E. D., Emmert-Buck, M. R., Liotta, L. A., Munson, P. J., and Krizman, D. B. Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol. Carcinog., 28: 12-22, 2000.
28. Knight, J. When the chips are down. Nature (Lond.), 410: 860-861, 2001.
29. Halgren, R. G., Fielden, M. R., Fong, C. J., and Zacharewski, T. R. Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones. Nucleic Acids Res., 29: 582-588, 2001.
30. Taylor, E., Cogdell, D., Coombes, K., Hu, L., Ramdas, L., Tabor, A., Hamilton, S., and Zhang, W. Sequence verification as quality-control step for production of cDNA microarrays. Biotechniques, 31: 62-65, 2001.
31. Pringault, E., Arpin, M., Garcia, A., Finidori, J., and Louvard, D. A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture. EMBO J., 5: 3119-3124, 1986.
32. Pringault, E., Robine, S., and Louvard, D. Structure of the human villin gene. Proc. Natl. Acad. Sci. USA, 88: 10811-10815, 1991.
33. Robine, S., Huet, C., Moll, R., Sahuquillo-Merino, C., Coudrier, E., Zweibaum, A., and Louvard, D. Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc. Natl. Acad. Sci. USA, 82: 8488-8492, 1985.
34. Dowell, E. D., Garrett, A. M., Shyr, Y., Johnson, D. H., and Hande, K. R. A randomized Phase II trial in patients with carcinoma of an unknown primary site. Cancer (Phila.), 91: 592-597, 2001.
35. Hickey, W. F., and Seiler, M. W. Ultrastructural markers of colonic adenocarcinoma. Cancer (Phila.), 47: 140-145, 1981.
36. Beer, D. G., Kardia, S. L. R., Huang, C-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M. G., Iannettoni, M. D., Orringer, M. B., and Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8: 816-824, 2002.
37. Giordano, T. J., Shedden, K. A., Schwartz, D. R., Kuick, R., Yaylor, J. M. G., Lee, N., Misek, D. E., Greenson, J. K., Kardia, S. L. R., Beer, D. G., Rennert, G., Cho, K. R., Gruber, S. B., Fearon, E. R., and Hanash, S. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol., 159: 1231-1238, 2001.
38. Bretscher, A., and Weber, K. Villin: the major microfilament-associated protein of the intestinal microvillus. Proc. Natl. Acad. Sci. USA, 76: 2321-2325, 1979.
39. Bretscher, A., and Weber, K. Villin is a major protein of the microvillus cytoskeleton which binds both G and F actin in a calcium-dependent manner. Cell, 20: 839-847, 1980.
40. Sharma, S., Tan, J., Sidhu, G., Wieczrek, R., Miller, D. C., and Cassi, N. D. Lung adenocarcinomas metastatic to the brain with and without ultrastructural evidence of rootlets: an electron microscopic and immunohistochemical study using cytokeratins 7 and 20 and villin. Ultrastruct. Pathol., 22: 385-391, 1998.
41. Bacchi, C. E., and Gown, A. M. Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab. Investig., 64: 418-424, 1991.
42. Lankes, W., Griesmacher, A., Grünwald, J., Schwartz-Albiez, R., and Keller, R. A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem. J., 251: 831-842, 1988.
43. Lankes, W. T., and Furthmayr, H. Moesin: a member of the protein 4. I-talin-ezrin family of proteins. Proc. Natl. Acad. Sci. USA, 88: 8297-8301, 1991.
44. Hayashi, K., Yonemura, S., Matsui, T., and Tsukita, S. Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxyl-terminal threonine phosphorylated in cultured cells and tissues. Application of a novel fixaton protocol using trichloroacetic acid (TCA) as a fixative. J. Cell. Sci., 112: 1149-1158, 1999.
45. Zhai, L., Zhao, P., Panebra, A., Guerrerio, A. L., and Khurana, S. Tyrosine phosphorylation of villin regulates the organization of the actin cytoskeleton. J. Biol. Chem., 276: 36163-36167, 2001.
46. Weinstein, J. N. Fishing expeditions. Science (Wash. DC), 282: 627, 1998.
47. Weinstein, J. N. "Omic" and hypothesis-driven research in the molecular pharmacology of cancer. Curr. Opin. Pharmacol., 2: 361-365, 2002.